Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

This study is testing whether a new capsule called TQH3906 can help control active psoriatic arthritis. Researchers will enroll 156 adults whose current treatments aren't working well enough. Participants will receive either the new drug, a placebo, or an existing medication for …

This study is testing a new drug, TQB2102, for people with advanced colorectal cancer that has a specific marker called HER2 IHC3+ and has stopped responding to standard treatments. About 142 participants will be randomly assigned to receive either the new drug or a treatment cho…